Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hopewell, S., Clarke, M., Lusher, A., Lefebvre, C., & Westby, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1191 · Cited by 116
Cited by
Taube, J. M., Anders, R. A., Young, G. D., Xu, H., Sharma, R., McMiller, T. L., Chen, S., Klein, A. P., Pardoll, D. M., Topalian, S. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003689 · Cited by 2,157
Survival in cancer of unknown primary site: population-based analysis by site and histology
Hemminki, K., Bevier, M., Hemminki, A., & Sundquist, J. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr536 · Cited by 161
“A recent review of the global literature on CUP melanoma identified skin involvement in 222 patients, visceral tissue involvement in 211 patients and bone involvement in 31 patients; median survival in the visceral involvement group was given as 3–16 months [28].”
BackgroundSurvival Is Not the Only Valuable End Point in Melanoma Screening
Curiel-Lewandrowski, C., Kim, C. C., Swetter, S. M., Chen, S. C., Halpern, A. C., Kirkwood, J. M., Leachman, S. A., Marghoob, A. A., Ming, M. E., & Grichnik, J. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.3 · Cited by 26
“In addition, it is unclear what percentage of cases presenting as metastatic melanoma of unknown primary (3.2% of melanomas) represent cases of primary lesions that would have been amenable for early detection (Kamposioras et al, 2010).”
BackgroundInfluential
Metadata
- Authors
- Kamposioras, K., Pentheroudakis, G., Pectasides, D., & Pavlidis, N.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 78
- Issue
- 2
- Pages
- 112-126
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2010973586
- Cited by
- 161
- References
- 1
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.